This brief report presents self-reports of recovery among adults aged 18 and older in the United States who thought they ever had a problem with their use of drugs or alcohol and/or mental health. These findings provide a clearer characterization of the factors associated with recovery among adults and how future efforts can foster a whole-health approach to sustain recovery from mental health and substance use conditions.

This document updates SAMHSA’s 2018 document and outlines best practices for the implementation and operation of recovery housing. These best practices are intended to serve as a tool for states, governing bodies, providers, recovery house operators, and other interested stakeholders to improve the health of their citizens, reduce incidence of overdose, and promote recovery housing as a key support strategy in achieving and sustaining recovery.

This guide reviews ways that telehealth modalities can be used to provide treatment for serious mental illness and substance use disorders among adults, distills the research into recommendations for practice, and provides examples of how these recommendations can be implemented.

This report discusses a technical expert panel convened to assess research about therapeutic services for youth living in foster care. It reviews the scientific evidence and expert panel input to identify action items and further research needs.

This report highlights programs that promote recovery and build resilience among older adolescents and young adults living with serious mental illness. It describes initiatives that address employment, housing, education, social connectedness, and emotional well-being.

This manual provides guidelines in screening and assessing teens for substance use conditions. It covers confidentiality laws, and screening and assessment in juvenile justice settings. The manual also includes screening and assessment tools.

This manual guides counselors in the use of medications to help clients achieve abstinence from alcohol. It describes how the medications work and whom may benefit. It also presents the side effects of three FDA-approved medications: acamprosate, disulfiram, and naltrexone.